ARCELLX INC has a total of 24 patent applications. Its first patent ever was published in 2016. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are NKARTA INC, ANGIEX INC and ARBELE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | Brazil | 3 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Philippines | 2 | |
#9 | Singapore | 2 | |
#10 | WIPO (World Intellectual Property Organization) | 2 | |
#11 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Combinatorial chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Hilbert David M | 14 |
#2 | Swers Jeffrey S | 12 |
#3 | Swers Jeffrey | 5 |
#4 | Hilbert David | 5 |
#5 | Lafleur David W | 5 |
#6 | Lafleur David William | 3 |
#7 | Lafleur David | 3 |
#8 | David M Hilbert | 3 |
#9 | Jeffrey S Swers | 2 |
#10 | David William Lafleur | 1 |
Publication | Filing date | Title |
---|---|---|
KR20200087176A | Multifunctional immune cell therapy | |
EP3710067A2 | D-domain containing polypeptides and uses thereof |